Norden Group’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.76M Sell
7,950
-706
-8% -$195K 0.14% 131
2026
Q1
$2.56M Buy
8,656
+1,232
+17% +$366K 0.25% 84
2025
Q4
$2.03M Buy
7,424
+516
+7% +$140K 0.2% 101
2025
Q3
$1.87M Sell
6,908
-255
-4% -$69.4K 0.19% 108
2025
Q2
$1.97M Buy
7,163
+833
+13% +$227K 0.21% 100
2025
Q1
$1.68M Buy
6,330
+147
+2% +$36.3K 0.19% 101
2024
Q4
$1.44M Buy
6,183
+1
+0% +$230 0.16% 132
2024
Q3
$1.36M Buy
+6,182
New +$1.28M 0.16% 139

Other funds holding CME

Norden Group's CME Position: Q2 2026 in Review

Norden Group reduced its CME Group (CME) stake by 8.2% in Q2 2026, selling an estimated $195K and leaving 7,950 shares worth $1.76M. The position accounts for 0.14% of the portfolio, ranked #131.

Norden Group first reported a position in CME in Q3 2024 and has held it in 8 quarters since. The position peaked at $2.56M in Q1 2026. 1,710 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Norden Group held 7,950 shares of CME Group worth $1.76M as of Q2 2026.
  • Norden Group sold 706 CME Group shares in Q2 2026, an estimated $195K.
  • CME Group made up 0.14% of Norden Group's portfolio in Q2 2026, its #131 holding.
  • Norden Group first reported a position in CME Group in Q3 2024 and has held it in 8 quarters since.
  • Norden Group's CME Group position peaked at $2.56M in Q1 2026.
  • 1,710 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Norden Group's 13F filing for Q2 2026, filed 29 Jul 2026.